Teva Pharmaceuticals USA Recall: Norepinephrine Bitartrate Injection, USP 4 mg/4 mL, 4 mL
Teva Pharmaceuticals USA Recall: Norepinephrine Bitartrate Injection, USP 4 mg/4 mL, 4 mL is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Teva Pharmaceuticals USA; Product: Norepinephrine Bitartrate Injection, USP 4 mg/4 mL, 4 mL single dose vials, packaged in 10 vial cartons (NDC 0703
| Recalling firm | Teva Pharmaceuticals USA |
|---|---|
| Product | Norepinephrine Bitartrate Injection, USP 4 mg/4 mL, 4 mL single dose vials, packaged in 10 vial cartons (NDC 0703-1153-03) Rx only, Teva Pharmaceuticals USA Inc. North Wales, PA 19454, vial NDC 0703-1153-01 |
| Reason for recall | Lack of Assurance of Sterility |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Product was distributed Nationwide, including Puerto Rico. |
| Recall initiated | 20210729 |
| Recall number | D-0739-2021 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →